(Q42487150)

1 November 2017

An in vitro model for the study of human bone marrow angiogenesis: role of hematopoietic cytokines (English)

1 reference

1 November 2017

Pelletier L

1

1 reference

1 November 2017

Regnard J

series ordinal

2

1 reference

1 November 2017

Fellmann D

series ordinal

3

1 reference

1 November 2017

Charbord P

series ordinal

4

1 reference

1 November 2017

1 April 2000

1 reference

1 November 2017

Laboratory Investigation

1 reference

1 November 2017

80

1 reference

1 November 2017

4

1 reference

1 November 2017

501-511

1 reference

https://scigraph.springernature.com/pub.10.1038/labinvest.3780056

1 November 2017

0 references

cites work

Polycythemia vera: stem-cell and probable clonal origin of the disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780056

Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780056

Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780056

Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780056

An activated form of transforming growth factor beta is produced by cocultures of endothelial cells and pericytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780056

Isolation of putative progenitor endothelial cells for angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780056

Multiple roles for integrins during development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780056

Human microvascular endothelial cells express receptors for platelet-derived growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780056

Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780056

Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780056

Requirement of vascular integrin alpha v beta 3 for angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780056

Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780056

Retroviral-mediated marker gene transfer in hematopoiesis-supportive marrow stromal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780056

Role of soluble mediators in angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780056

In vitro and in vivo activation of endothelial cells by colony-stimulating factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780056

Fighting cancer by attacking its blood supply

21 January 2018

2 references

https://api.crossref.org/works/10.1038%2FLABINVEST.3780056

21 January 2018

https://api.crossref.org/works/10.1038%2FLABINVEST.3780056

7 January 2021

Extracellular matrix and cell shape: potential control points for inhibition of angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780056

Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780056

Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780056

Modulation of angiogenesis by human glioma xenograft models that differentially express vascular endothelial growth factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780056

Phorbol esters induce angiogenesis in vitro from large-vessel endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780056

Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780056

Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780056

Basement Membrane Proteins: Structure, Assembly, and Cellular Interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780056

Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780056

Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780056

The broad spectrum of cytokine gene expression by myoid cells from the human marrow microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780056

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780056

Vascular development: cellular and molecular regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780056

7 January 2021

Recombinant human erythropoietin stimulates angiogenesis in vitro

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780056

7 January 2021

Definition of Two Angiogenic Pathways by Distinct alpha(v) Integrins

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780056

7 January 2021

The pathogenesis of myelofibrosis in myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780056

7 January 2021

Vascular outgrowths from tissue explants embedded in fibrin or collagen gels: a simple in vitro model of angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780056

7 January 2021

Parvalbumin relaxes frog skeletal muscle when sarcoplasmic reticulum Ca(2+)-ATPase is inhibited

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780056

7 January 2021

Endothelial cell proliferation in myelofibrosis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780056

7 January 2021

Indispensable role of tissue-type plasminogen activator in growth factor-dependent tube formation of human microvascular endothelial cells in vitro

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780056

7 January 2021

Cytokines active on granulomonopoiesis: release and consumption by human marrow myoid [corrected] stromal cells

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780056

7 January 2021

Microenvironmental factors involved in the establishment of erythropoiesis in bone marrow.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780056

7 January 2021

10.1038/LABINVEST.3780056

Identifiers

DOI

1 reference

1 November 2017

1 reference